Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Moses
Badio
;
Edouard
Lhomme
;
Mark
Kieh
;
Abdoul Habib
Beavogui
;
Stephen B
Kennedy
;
Seydou
Doumbia
;
Bailah
Leigh
;
Samba O
Sow
;
Alpha
Diallo
;
Daniela
Fusco
;
+16 more...
Matthew
Kirchoff
;
Monique
Termote
;
Renaud
Vatrinet
;
Deborah
Wentworth
;
Helène
Esperou
;
H Clifford
Lane
;
Jerome
Pierson
;
Deborah
Watson-Jones
;
Céline
Roy
;
Eric
D'Ortenzio
;
Brian
Greenwood
;
Genevieve
Chêne
;
Laura
Richer
;
James D
Neaton
;
Yazdan
Yazdanpanah
;
PREVAC study team
;
PREVAC study team;
(2021)
Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Trials, 22 (1).
583-.
ISSN 1745-6215
DOI: 10.1186/s13063-021-05572-3
Following the publication of the original article [1], we were notified of an error in the affiliation of 3 authors of the article: Celine Roy, Laura Richert and Genevieve Chene. Their affiliation was initially mentioned as: “Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia” However, their correct affiliation is: Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.tp.
Item Type | Article |
---|---|
Elements ID | 165979 |
Date Deposited | 09 Nov 2021 11:49 |
ORCID: https://orcid.org/0000-0001-6247-1746
ORCID: https://orcid.org/0000-0001-5725-9118